Ann: Monthly Activities/Appendix 4C Cash Flow Report, page-7

I don't know what to think of these cannabis stocks. I've held a few now and know that they have been massive cash burners and I have been on the end of some decent losses. However, I use the Adaya 10/10 which works pretty well for me for chronic pain. It costs $250 a month which equates to $3k per year. Mental health and chronic pain are two huge issues within our modern communities and they won't be going away anytime soon. in terms of Australia, if 5000 people were using the same amt of Adaya as I am (which is a pretty standard dose) this would correlate to $15 000 000 in revenue. That is, less than 0.0002 of the population. I don't know what the margins are but I do know that it is one of the cheapest (if not the cheapest) 10/10 on the market. Just see food for thought for holders of this stock. To me it's worth the gamble.....for now